Dermatology

This site is intended for healthcare professionals only

Login Register

MD Brand Connect
Webinars
Vaccine Hub
MDTV
Fact Check
Health Dialogues

Medical News & Guidelines
Health news
Fact Check
AYUSH
State News
Medical Education
Industry
MDTV

This site is intended for healthcare professionals only

Login Register

LoginRegister

Home
Medical news & Guidelines
Health news
Fact Check
AYUSH
State News
Medical Education
Industry

Ruchika Sharma

Ruchika Sharma joined Medical Dialogue as an Correspondent for the Business Section in 2019. She covers all the updates in the Pharmaceutical field, Policy, Insurance, Business Healthcare, Medical News, Health News, Pharma News, Healthcare and Investment. She has completed her B.Com from Delhi University and then pursued postgraduation in M.Com. She can be contacted at editorial@medicaldialogues.in Contact no. 011-43720751

Home

Ruchika Sharma

Articles By : Ruchika Sharma

Lupin Partners with TB Alliance to Advance Telacebec for TB, Leprosy and Buruli Ulcer

Intas Pharma, Syna Therapeutics ink pact for commercialization of LB-0702 in Global Markets

Ruchika Sharma6 Nov 2022 2:00 PM IST

Ahmedabad: Syna Therapeutics, a joint venture of Reig Jofre and Leanbio, has signed a global rights licensing deal with Intas Pharmaceuticals...

Novo Nordisk to boost obesity drugs manufacturing capacity

Ruchika Sharma6 Nov 2022 12:00 PM IST

Frankfurt: Novo Nordisk said it will boost manufacturing capacity for future obesity drug launches and worry less about marketing and advertising...

Moderna COVID vaccine sales forecasts fall short for 2022, 2023

Ruchika Sharma6 Nov 2022 10:00 AM IST

Cambridge: Moderna Inc has cut its 2022 COVID-19 vaccine sales forecast, citing regulatory and production delays, and issued a 2023 outlook...

Novavax appoints Rick Rodgers as new Independent director

Ruchika Sharma5 Nov 2022 4:06 PM IST

Gaithersburg: Novavax, Inc. has announced the appointment of Richard Rodgers, MBA to its board as an independent director. Mr. Rodgers brings...

USFDA grants priority review to Sanofi-Regeneron Dupixent for bullous pemphigoid

Sanofi gets European Commission nod for Beyfortus to prevent RSV disease in infants

Ruchika Sharma5 Nov 2022 3:00 PM IST

RSV is the most common cause of LRTI, including bronchiolitis and pneumonia, in infants.

Official says India looking at greater market access for pharma products in UK under proposed FTA

Ruchika Sharma5 Nov 2022 1:45 PM IST

New Delhi: India is looking at greater market access for its pharmaceutical products in the UK as part of the proposed free trade agreement with...

Raid: Fake Ayurvedic, Allopathic medicine worth Rs one crore recovered from UP manufacturing unit, 2 held

Ruchika Sharma5 Nov 2022 12:30 PM IST

Sambhal: Two men were arrested after a raid was conducted at a manufacturing unit involved in making fake Ayurvedic and Allopathic medicine, police...

Cipla reports bigger-than-expected 11 percent increase in Q2 profit

Ruchika Sharma5 Nov 2022 11:15 AM IST

Total revenue from operations increased 5 percent to 57.59 billion rupees.

Pfizer-BioNTech to test combined COVID, influenza vaccine

Ruchika Sharma4 Nov 2022 3:40 PM IST

Frankfurt: Pfizer-BioNTech said they will test a combined coronavirus and influenza vaccine, which could potentially pave the way for better...

$Pfizer Elranatamab gets USFDA Breakthrough Therapy Designation for Relapsed or Refractory Multiple Myeloma$

Powered By: Hocalwire

X

We use cookies for analytics, advertising and to improve our site. You agree to our use of cookies by continuing to use our site. To know more, see our Cookie Policy and Cookie Settings.Ok

Articles By : Ruchika Sharma

Intas Pharma, Syna Therapeutics ink pact for commercialization of LB-0702 in Global Markets

Novo Nordisk to boost obesity drugs manufacturing capacity

Moderna COVID vaccine sales forecasts fall short for 2022, 2023

Novavax appoints Rick Rodgers as new Independent director

Sanofi gets European Commission nod for Beyfortus to prevent RSV disease in infants

Official says India looking at greater market access for pharma products in UK under proposed FTA

Raid: Fake Ayurvedic, Allopathic medicine worth Rs one crore recovered from UP manufacturing unit, 2 held

Cipla reports bigger-than-expected 11 percent increase in Q2 profit

Pfizer-BioNTech to test combined COVID, influenza vaccine

Pfizer Elranatamab gets USFDA Breakthrough Therapy Designation for Relapsed or Refractory Multiple Myeloma

Lupin bags USFDA nod for generic equivalent of Slynd Tablets

GSK gets USFDA priority review for RSV older adult vaccine